MANTRA (Heart Valve Disease)

MANTRA (Heart Valve Disease)

Es posible que algunos contenidos no estén disponibles en español.

Purpose of this Study

We are doing this study to learn more about heart valve disease and its standard-of-care treatments, and we want to learn more about the safety and performance of the Corcym devices and accessories used for heart valve disease.

Who Can Participate?

Eligibility

Adults with heart valve disease who will be treated with a Corcym heart valve device. For more information about who can join this study, please contact the study team at hillary.hood@duke.edu.

Age Range

18-110

Sex/Genders

Male (cisgender)
Female (cisgender)
Non-binary or gender fluid
Transgender male
Transgender female
Looking for Healthy Participants
No

What is Involved?

Description

If you choose to join this study, we will collect information related to your heart valve surgery from your medical records and phone calls with you. This information will collected before your surgery and for up to 10 years. You may be asked to return to Duke for a yearly echocardiogram if you do not have this done as part of your routine care.

Locations

Duke University Hospital

Visit Timing

Weekdays

Compensation

Yes

Spanish Materials Available

No

Study Details

Full Title

Corcym Mitral, Aortic aNd Tricuspid post-maRket Study in a reAl-world setting

Principal Investigator

George
Hughes

Protocol Number

PRO00110315

Phase

N/A

Enrollment Status

Open to Enrollment